Chatham House, February 9-10


FREE DRUG DISCOVERY CONFERENCE IN THE HEART OF EUROPE

MipTec is the largest drug discovery conference in Europe with over 3,000 delegates from pharmaceutical companies

ATTEND 10 OTHER SCIENTIFIC FORUMS AT MIPTEC

Stem Sells, Translational Medicine, Protein Therapeutics, Medicinal Chemistry and others

IN SILICO APPROACHES TO GEROPROTECTOR DISCOVERY AND DRUG REPURPOSING

New in silico approaches to evaluating the efficacy of and repurposing drugs for aging and age-related diseases

MEET YOUNG PROSPECTIVE SCIENTISTS AND RESEARCH MANAGERS

The forum will attract many young scientists in aging research providing the possibility to recruit scarse talent with unique skills and interests

AGING CONFERENCE FOCUSED ON REINVENTINT THE PHARMA INDUSTRY

Unlike other aging conferences, the forum is geared towards the pharmaceutical industry addressing the need for new markers and new drugs within the traditional regulatory frameworks

Monday, May 4, 2015

Insilico Medicine SuperPharman Challenge: Looking for Superheros to Fight Aging

Super Heroes Needed at Insilico Medicine to Fight Cancer and Age-related Diseases



Aging fighters at Insilico Medicine are looking for relentless doers who dream big, but are not afraid to get their hands dirty with basic tasks. Doers, who have trouble sleeping at night, because they know that millions of people are suffering and dying of cancer and age-related diseases and their own clock is ticking as well. Doers with both programming and database management skills and knowledge of biology. You will need to know or quickly learn how to use huge multi-omics data to find alternative uses of currently available drugs and distribute many micro tasks to the crowd, freelancers or colleagues, while keeping the big picture in mind. 

We know that we are looking for a needle in the haystack, but this is how our team has come to be and you will be in great company. We have relentless super heroes in the US, UK, Switzerland, Poland, Israel, Russia and China. If you know someone amazing, who fits that profile amazing, ask him. Maybe he or she is already working for us. He goes through the day doing a boring academic job, but at night he is hacking away.

Our first frontier is transforming the pharmaceutical industry, repurposing known drugs and finding the new ones. When we launch, the world will become a better place. And if you are that super hero with bold ideas and hands on experience, ready to unleash maniacal energy to hack aging, send us a signal and we will respond right away or start watching you to see if you fit.

Here is a link to what Insilico Medicine is doing: 


In partnerships they can also do in vitro and in vivo validation, humouse clinical trials and even organ-on-a-chip and body-on-a-chip validation. 
They are looking for someone with similar skill set and energy as Alex Zhavoronkov (www.linkedin.com/in/zhavoronkov) to work together with him, gradually replace him and then find someone to replace yourself as the company grows or you decide to start a subsidiary. 

Minimum requirements:
  • Python, MySQL, Hadoop, AWS Services, IBM Watson
  • Experience working with multi-omics data and/or clinical trials/biomedical text data
  • SVM and deep learning algorithms
  • Basic knowledge of signaling and metabolic pathways
  • Experience working with GEO, ArrayExpress, KEGG, TCGA, LINCS, Connectivity Map, Drugbank, Clinical Trials, WHO databases, etc.
  • Personal network of contacts in academia and large pharmaceutical companies
  • Excellent writing skills
  • Ability to give public talks and generate publicity is a plus
  • Knowledge of Russian, Chinese or Hebrew is a plus




Sunday, January 4, 2015

Featured Conference: Chatham House

 

Ageing and Health – Policy and economics in an era of longevity

9th–10th February, 2015

A two-day international conference at ChathamHouse, London

Register Now
How can societies meet the health, policy and economic challenges of global population ageing?

One in nine people in the world is 60 or older and this is expected to rise to one in five people by 2050. A globally ageing population and the associated demographic changes have wide-ranging implications for health systems, medical priorities, economic policies, and labour and consumer markets.

The certainty of global population ageing demands greater action, innovation, and a long-term approach from policymakers, health and medical professionals as well as businesses. This conference will address critical questions, including:
  • Are current health, public policy and economic responses to global ageing adequate?
  • How can health systems develop sustainable strategies to support an ageing global population?
  • How can the challenge of managing chronic conditions be met and at what cost?
  • How can societies address the financial impact of ageing populations?
  • Are businesses reacting quickly enough to an ageing workforce and consumer base?
Speakers include:
  • László Andor, Commissioner for Employment, Social Affairs and Inclusion (2010-14), European Commission
  • Xiao Caiwei, Vice President, China National Committee on Ageing
  • Professor Kevin Fenton, Director of Health and Wellbeing, Public Health England
  • Dr Josep Figueras, Director, European Observatory on Health Systems and Policies
  • Dr Richard Jackson, President, Global Aging Institute
  • Dr Michael W Hodin, Executive Director, Global Coalition on Aging
  • Professor Tom Kirkwood, Dean for Ageing, Newcastle University Institute for Ageing
  • Dr Kiyoshi Kurokawa, Professor of the National Graduate Institute for Policy Studies; Chair, Health and Global Policy Institute, Japan
  • Dr Husseini Manji, Global Therapeutic Head for Neuroscience, Janssen Research & Development
  • Sarbjit Nahal, Head of Thematic Investing Strategy, Bank of America Merrill Lynch
  • Alana Officer, Senior Health Adviser, Ageing and Life Course, World Health Organization
  • Daniel Ryan, Head, Life and Health Research and Development, Swiss Re
  • Simon Stevens, Chief Executive, NHS England
  • Jannette Spiering, Director, De Hogeweyk Dementia Village
  • Nicoline Vackerberg, Coordinator, The Esther Network
For the full agenda, the speaker line up and to register please visit the event website.
Copyright © 2014 Biogerontology Research Foundation, All rights reserved.
We're reaching out to you as a relevant contact we hope is interested in our work.

Our mailing address is:
Biogerontology Research Foundation
Apt 2354
Chynoweth House, Trevissome Park
Truro, TR4 8UN
United Kingdom

Wednesday, December 10, 2014

Featured conference: A4M las Vegas

Featured conference: A4M las VegasDecember 11-13


Keynote Presenters

December 11th  |  David Katz, MD, MPH, FACP Top

Dr. David KatzDr. Katz is the founding (1998) director of Yale University's Prevention Research Center. He received his BA from Dartmouth College in three years (1984; Magna Cum Laude); his MD from the Albert Einstein College of Medicine (1988); and his MPH from the Yale University School of Public Health (1993). He is a two-time diplomate of the American Board of Internal Medicine, a board-certified specialist in Preventive Medicine/Public Health, and a clinical instructor in medicine at the Yale School of Medicine.

December 12th  |  J. Craig Venter, PhD Top

Dr. J. Craig VenterJ. Craig Venter, Ph.D., is regarded as one of the leading scientists of the 21st century for his numerous invaluable contributions to genomic research. He is Founder, Chairman, and CEO of the J. Craig Venter Institute (JCVI), a not-for-profit, research organization with approximately 300 scientists and staff dedicated to human, microbial, plant, synthetic and environmental genomic research, and the exploration of social and ethical issues in genomics.

Dr. Venter is Founder and CEO of Synthetic Genomics Inc (SGI), a privately held company dedicated to commercializing genomic-driven solutions to address global needs such as new sources of energy, new food and nutritional products, and next generation vaccines.

December 13th  |  Alexander Zhavoronkov, PhD Top

Dr. Alexander ZhavoronkovAlex Zhavoronkov, PhD, is the director and a trustee of the Biogerontology Research Foundation, a UK-based think tank supporting aging research worldwide and is the founder of the International Aging Research Portfolio, a curated knowledge management system for aging research. He heads the laboratory of regenerative medicine at the Clinical Research Center for Pediatric Hematology, Oncology and Immunology where his research interests include Hutchinson-Gilford Syndrome, new methods of cellular reprogramming, molecular mechanisms of skin and cartilage regeneration and personalized medicine in oncology. He is also the international adjunct professor at the Moscow Institute of Physics and Technology.


Friday, October 3, 2014

Everyday drugs could give extra years of life - New Scientist

Great article on New Scientist by the talented science journalist Clare Wilson covering the Aging Forum.



Everyday drugs could give extra years of life - health - 01 October 2014 - New Scientist

Thursday, June 26, 2014

Should we Treat Aging as a Disease? Academic, pharmaceutical, healthcare policy and pension fund perspectives

Are you an expert in biomedical sciences, medical doctor, economist, data scientist, actuary, pensions fund manager? Would you like to influence research, healthcare and retirement policy and help governments, companies and individuals prepare for the rapidly changing future?
Please consider contributing a research paper, review, perspective or opinion to the new research topic in Frontiers in Genetics, "Should we Treat Aging as a Disease? Academic, pharmaceutical, healthcare policy and pension fund perspectives". 

Frontiers is one of the top credible open access publishers co-owned by the Nature Publishing Group. It is staying ahead of the other OA publishers by introducing the cutting edge tools for scientists to disseminate their research and ideas.

The burden of the aging on the economies of the developed countries in the form of rapidly increasing dependency ratios and unfunded social security and healthcare liabilities is turning the quest to increase healthy life spans into a pressing economic priority required to preserve the current standards of living. There is an urgent need to develop and validate interventions with geroprotective properties to increase the productive health spans of the working population and maintaining performance and avoiding loss of function.

The key opinion leaders in academia, the pension fund community, government and pharmaceutical industry have voiced concerns about the possible crisis and made calls to transform the current research and healthcare paradigms to focus on increasing the healthy productive longevity by refocusing the efforts from treatment to prevention.

One of the impediments for the industry transformation is the way aging is treated. And while no doubt exists that aging is a complex multifactorial process with no single cause or treatment, the issue whether aging can be classified as the disease is widely debated. This disagreement leads to the inability to classify aging as a disease and fit the possible treatment options into the established research, regulatory, insurance and marketing frameworks. Is it time to put the philosophical disagreements aside and start treating aging as the disease in a concerted attempt to increase productive longevity?

The intent of this research topic is to combine the perspectives and reviews from the representatives of the academic and non-profit research community as well as from the pension funds, insurance organizations and pharmaceutical companies.

Saturday, June 14, 2014

September 2014

The most important event in boimedicine this year will be the Aging Forum at MipTec in Basel, Switzerland. Registration is FREE. Over 3,000 delegates from the large pharmaceutical companies are expected to attend the event. Visit www.miptec.ch and www.agingpharma.org


ConferenceName
StartDate
EndDate
Days
Location

2014 International Conference on Mechanical, Aeronautical and Automotive Engineering (ICMAA 2014)
9/4/14
9/5/14
2
Kuala Lumpur; Malaysia
http://www.icmaa.org/
2014 3rd International Conference on Engineering and Innovative Materials (ICEIM 2014)
9/4/14
9/5/14
2
Kuala Lumpur; Malaysia
http://www.iceim.org/
2014 4th International Conference on Energy and Environmental Science (ICEES 2014)
9/4/14
9/5/14
2
Kuala Lumpur; Malaysia
http://www.icees.org/
2014 International Conference on Mechatronics and Mechanical Engineering (ICMME 2014)
9/6/14
9/8/14
3
Chengdu; China
http://www.icmme.org/
2014 International Conference on Manufacturing and Optimization (ICMO 2014)
9/6/14
9/8/14
3
Chengdu; China
http://www.icmo.org/
2014 International Conference on Information and Computer Technology (ICICT 2014)
9/6/14
9/8/14
3
Chengdu; China
http://www.icict.org/
EuroSense 2014: 6th European Conference on Sensory and Consumer Research
9/7/14
9/10/14
4
Copenhagn; Denmark
http://www.eurosense.elsevier.com/index.html
International Conference on Engineering Science and Chemical Technologies
9/8/14
9/10/14
3
Houston ; Texas  United States of America
http://www.petrotex.us
2014 International Conference on Automotive Engineering and Intelligent Manufacturing (CAEIM 2014)
9/8/14
9/10/14
3
Tbilisi; Georgia
http://www.caeim.net/
ICT Innovations 2014
9/9/14
9/12/14
4
Ohrid; Macedonia
http://www.ict-act.org/
2014 BGI International Bioinformatics Workshop
9/15/14
9/18/14
4
Shenzhen; China
http://events.genomics.cn/en/training/show_training?id=121
2014 6th International Conference on Chemical, Biological and Environmental Engineering (ICBEE 2014)
9/15/14
9/16/14
2
Paris; France
http://www.icbee.org/
2014 4th International Conference on Biotechmology and Environmental Management (ICBEM 2014)
9/15/14
9/16/14
2
Paris; France
http://www.icbem.org/
2014 6th International Conference on Software Technology and Engineering (ICSTE 2014)
9/17/14
9/18/14
2
Paris; France
http://www.icste.org/
INTERNATIONAL CONFERENCE ON CHEMICAL, ENVIRONMENT &amp
9/17/14
9/18/14
2
Kuala Lumpur; Malaysia
http://www.iicbe.org/2014/09/20/49
3rd International Conference on Applied Life Sciences (ICALS 2014)
9/18/14
9/20/14
3
Bangi; Malaysia
http://www.isals.org/icals2014
Practical Applications of Aging Research for Drug Discovery
9/23/14
9/24/14
2
Basel Switzerland
http://www.agingpharma.org
AIAI 2014
9/19/14
9/22/14
4
Rhodes; Greece
http://delab.csd.auth.gr/aiai2014/
Uranium Mining and Hydrogeology 2014 International Conference (UMH VII)
9/21/14
9/25/14
5
Freiberg; Saxony Germany
http://tu-freiberg.de/umh-vii-2014
2nd Annual Congress of the European Society for Translational Medicine & Global Network Conference on Translational Medicine (EUSTM-2014)
9/22/14
9/25/14
4
Vienna; Austria
http://www.eutranslationalmedicine.org/eustm-2014
Southern African HIV Clinicians Society Conference 2014
9/24/14
9/27/14
4
Cape Town; South Africa
http://www.sahivsoc2014.co.za
3rd International Conference on Clinical Microbiology and Microbial Genomics
9/24/14
9/26/14
3
Valencia; Spain
http://clinicalmicrobiology2014.conferenceseries.net/index.php
Are there limits to evolution?
9/25/14
9/26/14
2
Cambridge; Cambridgeshire United Kingdom
https://wserv4.esc.cam.ac.uk/atle/
2014 The 3rd International Conference on Wireless Networks (ICWN 2014)
9/26/14
9/27/14
2
Bali; Indonesia
http://www.icwn.org/
2014 2nd International Conference on Biological and Medical Sciences (ICBMS 2014)
9/27/14
9/28/14
2
Bali; Indonesia
http://www.icbms.org/
International Bioscience Conference 2014
9/29/14
9/30/14
2
Phuket; Thailand
https://ibsc2014.com/
DNA Replication as a Source of DNA Damage
9/30/14
10/3/14
4
El Jadida; Morocco
http://www.fusion-conferences.com/conference3.php